Side-by-side comparison of AI visibility scores, market position, and capabilities
Telehealth platform for men's hormone optimization; at-home blood test followed by virtual consultation with board-certified physicians for testosterone replacement and hormonal treatment.
Hone Health is a telehealth platform focused on hormone optimization for men, providing access to board-certified physicians who specialize in testosterone replacement therapy, growth hormone peptides, and related hormonal treatments through a fully virtual care model. The platform begins with an at-home blood test that measures testosterone, thyroid hormones, cortisol, metabolic markers, and other biomarkers relevant to hormonal health, with results reviewed by a Hone-affiliated physician who conducts a virtual consultation to discuss findings and treatment options. This laboratory-driven intake process allows for a clinically grounded starting point rather than symptom-based self-reporting alone, and creates a baseline for tracking patient progress over time.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.